Diflunisal vs placebo
Number of participants experiencing at least one severe adverse event · people with TTR‐FAP
It is very uncertain whether diflunisal changes number of participants experiencing at least one severe adverse event compared with placebo (very low certainty).
1 finding from 1 review
- Pharmacological treatment for familial amyloid polyneuropathy 2020 · Cochrane Headline outcomes onlyRR 0.77 [0.18, 3.32]1 study · 130 participantsVery low